-
1
-
-
77949568869
-
Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain
-
Adamiak B, et al. 2010. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain. Virology 400:197-206.
-
(2010)
Virology
, vol.400
, pp. 197-206
-
-
Adamiak, B.1
-
2
-
-
0034921526
-
Sorting out the new HSV type specific antibody tests
-
Ashley RL. 2001. Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect. 77:232-237.
-
(2001)
Sex. Transm. Infect.
, vol.77
, pp. 232-237
-
-
Ashley, R.L.1
-
3
-
-
0032923917
-
Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection
-
Ashley RL, Eagleton M, Pfeiffer N. 1999. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J. Clin. Microbiol. 37:1632-1633.
-
(1999)
J. Clin. Microbiol.
, vol.37
, pp. 1632-1633
-
-
Ashley, R.L.1
Eagleton, M.2
Pfeiffer, N.3
-
4
-
-
0023473319
-
Use of densitometric analysis for interpreting HSV serologies based on Western blot
-
Ashley RL, Militoni J. 1987. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J. Virol. Methods 18:159-168.
-
(1987)
J. Virol. Methods
, vol.18
, pp. 159-168
-
-
Ashley, R.L.1
Militoni, J.2
-
5
-
-
0023837735
-
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera
-
Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
-
(1988)
J. Clin. Microbiol.
, vol.26
, pp. 662-667
-
-
Ashley, R.L.1
Militoni, J.2
Lee, F.3
Nahmias, A.4
Corey, L.5
-
6
-
-
0037383018
-
Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2
-
Ashley-Morrow R, Krantz E, Wald A. 2003. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex. Transm. Dis. 30:310-314.
-
(2003)
Sex. Transm. Dis.
, vol.30
, pp. 310-314
-
-
Ashley-Morrow, R.1
Krantz, E.2
Wald, A.3
-
7
-
-
0034948896
-
A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes
-
Baldi P, Long AD. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509-519.
-
(2001)
Bioinformatics
, vol.17
, pp. 509-519
-
-
Baldi, P.1
Long, A.D.2
-
8
-
-
0024593560
-
A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein
-
Banks T, et al. 1989. A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. J. Gen. Virol. 70(Pt 4):979-985.
-
(1989)
J. Gen. Virol.
, vol.70
, Issue.PART 4
, pp. 979-985
-
-
Banks, T.1
-
9
-
-
78650370215
-
Herpes simplex virus type 2 seropositivity and relationship status among U S. adults age 20 to 49 a population-based analysis
-
Bauer GR, Khobzi N, Coleman TA. 2010. Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis. BMC Infect. Dis. 10:359.
-
(2010)
BMC Infect. Dis.
, vol.10
, pp. 359
-
-
Bauer, G.R.1
Khobzi, N.2
Coleman, T.A.3
-
10
-
-
0001677717
-
Controlling the false discovery rate: a practical and powerful approach to multiple testing
-
Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57:289-300.
-
(1995)
J. R. Stat. Soc. B
, vol.57
, pp. 289-300
-
-
Benjamini, Y.1
Hochberg, Y.2
-
11
-
-
0042890384
-
Identification of novel immunodominant CD4+Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity
-
BenMohamed L, et al. 2003. Identification of novel immunodominant CD4+Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J. Virol. 77:9463-9473.
-
(2003)
J. Virol.
, vol.77
, pp. 9463-9473
-
-
BenMohamed, L.1
-
12
-
-
0030792120
-
The acquisition of herpes simplex virus during pregnancy
-
Brown ZA, et al. 1997. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337:509-515.
-
(1997)
N. Engl. J. Med.
, vol.337
, pp. 509-515
-
-
Brown, Z.A.1
-
13
-
-
0037425558
-
Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant
-
Brown ZA, et al. 2003. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203-209.
-
(2003)
JAMA
, vol.289
, pp. 203-209
-
-
Brown, Z.A.1
-
14
-
-
0023387940
-
Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection
-
Cantin EM, et al. 1987. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. U.S.A. 84:5908-5912.
-
(1987)
Proc. Natl. Acad. Sci. U.S.A.
, vol.84
, pp. 5908-5912
-
-
Cantin, E.M.1
-
15
-
-
0029859491
-
T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2
-
Carmack MA, et al. 1996. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J. Infect. Dis. 174:899-906.
-
(1996)
J. Infect. Dis.
, vol.174
, pp. 899-906
-
-
Carmack, M.A.1
-
16
-
-
77951244078
-
Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States 2005-2008
-
CDC
-
CDC. 2010. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb. Mortal. Wkly. Rep. 59:456-459.
-
(2010)
MMWR Morb. Mortal. Wkly. Rep.
, vol.59
, pp. 456-459
-
-
-
17
-
-
56449115358
-
Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B
-
Chentoufi AA, et al. 2008. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J. Virol. 82:11792-11802.
-
(2008)
J. Virol.
, vol.82
, pp. 11792-11802
-
-
Chentoufi, A.A.1
-
18
-
-
40449086460
-
HLA- A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D
-
Chentoufi AA, et al. 2008. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J. Immunol. 180:426-437.
-
(2008)
J. Immunol.
, vol.180
, pp. 426-437
-
-
Chentoufi, A.A.1
-
19
-
-
0033612702
-
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials Chiron HSV Vaccine Study Group
-
Corey L, et al. 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 282:331-340.
-
(1999)
JAMA
, vol.282
, pp. 331-340
-
-
Corey, L.1
-
20
-
-
77951078453
-
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray
-
Crompton PD, et al. 2010. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 107:6958-6963.
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 6958-6963
-
-
Crompton, P.D.1
-
21
-
-
0030853022
-
Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the Hybrid Capture II signal amplification probe test
-
Cullen AP, Long CD, Lorincz AT. 1997. Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the Hybrid Capture II signal amplification probe test. J. Clin. Microbiol. 35:2275-2278.
-
(1997)
J. Clin. Microbiol.
, vol.35
, pp. 2275-2278
-
-
Cullen, A.P.1
Long, C.D.2
Lorincz, A.T.3
-
22
-
-
0027514853
-
A cosmid-based system for constructing mutants of herpes simplex virus type 1
-
Cunningham C, Davison AJ. 1993. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197:116-124.
-
(1993)
Virology
, vol.197
, pp. 116-124
-
-
Cunningham, C.1
Davison, A.J.2
-
23
-
-
68049127746
-
New concepts in herpes simplex virus vaccine development: notes from the battlefield
-
Dasgupta G, Chentoufi AA, Nesburn AB, Wechsler SL, BenMohamed L. 2009. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev. Vaccines 8:1023-1035.
-
(2009)
Expert Rev. Vaccines
, vol.8
, pp. 1023-1035
-
-
Dasgupta, G.1
Chentoufi, A.A.2
Nesburn, A.B.3
Wechsler, S.L.4
BenMohamed, L.5
-
24
-
-
20044369888
-
Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery
-
Davies DH, et al. 2005. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. U.S.A. 102:547-552.
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 547-552
-
-
Davies, D.H.1
-
25
-
-
0034659112
-
Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections
-
Deshpande SP, Kumaraguru U, Rouse BT. 2000. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections. Cell. Immunol. 202:79-87.
-
(2000)
Cell. Immunol.
, vol.202
, pp. 79-87
-
-
Deshpande, S.P.1
Kumaraguru, U.2
Rouse, B.T.3
-
26
-
-
0031935813
-
The genome sequence of herpes simplex virus type 2
-
Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ. 1998. The genome sequence of herpes simplex virus type 2. J. Virol. 72:2010-2021.
-
(1998)
J. Virol.
, vol.72
, pp. 2010-2021
-
-
Dolan, A.1
Jamieson, F.E.2
Cunningham, C.3
Barnett, B.C.4
McGeoch, D.J.5
-
27
-
-
0026765465
-
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C
-
Dolter KE, Goins WF, Levine M, Glorioso JC. 1992. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J. Virol. 66:4864-4873.
-
(1992)
J. Virol.
, vol.66
, pp. 4864-4873
-
-
Dolter, K.E.1
Goins, W.F.2
Levine, M.3
Glorioso, J.C.4
-
28
-
-
0025789927
-
Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity
-
Dubin G, Socolof E, Frank I, Friedman HM. 1991. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 65:7046-7050.
-
(1991)
J. Virol.
, vol.65
, pp. 7046-7050
-
-
Dubin, G.1
Socolof, E.2
Frank, I.3
Friedman, H.M.4
-
29
-
-
0012572299
-
A variancestabilizing transformation for gene-expression microarray data
-
Durbin BP, Hardin JS, Hawkins DM, Rocke DM. 2002. A variancestabilizing transformation for gene-expression microarray data. Bioinformatics 18(Suppl 1):S105-S110.
-
(2002)
Bioinformatics
, vol.18
, Issue.SUPPL. 1
-
-
Durbin, B.P.1
Hardin, J.S.2
Hawkins, D.M.3
Rocke, D.M.4
-
30
-
-
0022337655
-
Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge
-
Eisenberg RJ, et al. 1985. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J. Virol. 56:1014-1017.
-
(1985)
J. Virol.
, vol.56
, pp. 1014-1017
-
-
Eisenberg, R.J.1
-
31
-
-
69449101951
-
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens
-
Felgner PL, et al. 2009. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc. Natl. Acad. Sci. U.S.A. 106:13499-13504.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 13499-13504
-
-
Felgner, P.L.1
-
32
-
-
0030744945
-
Herpes simplex virus type 2 in the United States 1976 to 1994
-
Fleming DT, et al. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105-1111.
-
(1997)
N. Engl. J. Med.
, vol.337
, pp. 1105-1111
-
-
Fleming, D.T.1
-
33
-
-
29144444035
-
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
-
Freeman EE, et al. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73-83.
-
(2006)
AIDS
, vol.20
, pp. 73-83
-
-
Freeman, E.E.1
-
34
-
-
0033021239
-
Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by themajority of patients infected with HSV-2, but not by those infected with HSV-1
-
Grabowska A, et al. 1999. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by themajority of patients infected with HSV-2, but not by those infected with HSV-1. J. Gen. Virol. 80(Pt 7):1789-1798.
-
(1999)
J. Gen. Virol.
, vol.80
, Issue.PART 7
, pp. 1789-1798
-
-
Grabowska, A.1
-
35
-
-
0020326053
-
Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody
-
Hayashida I, et al. 1982. Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody. Microbiol. Immunol. 26:497-509.
-
(1982)
Microbiol. Immunol.
, vol.26
, pp. 497-509
-
-
Hayashida, I.1
-
36
-
-
84355165249
-
Measurement of antibody responses to modified vaccinia virus Ankara (MVA) and Dryvax® using proteome microarrays and development of recombinant protein ELISAs
-
Hermanson G, et al. 2012. Measurement of antibody responses to modified vaccinia virus Ankara (MVA) and Dryvax® using proteome microarrays and development of recombinant protein ELISAs. Vaccine 30:614-625.
-
(2012)
Vaccine
, vol.30
, pp. 614-625
-
-
Hermanson, G.1
-
37
-
-
33646734890
-
Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes
-
Hosken N, et al. 2006. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J. Virol. 80:5509-5515.
-
(2006)
J. Virol.
, vol.80
, pp. 5509-5515
-
-
Hosken, N.1
-
38
-
-
11244346557
-
Variance stabilization applied to microarray data calibration and to the quantification of differential expression
-
Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. 2002. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96-S104.
-
(2002)
Bioinformatics
, vol.18
, Issue.SUPPL. 1
-
-
Huber, W.1
von Heydebreck, A.2
Sultmann, H.3
Poustka, A.4
Vingron, M.5
-
39
-
-
0028846789
-
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis
-
Incorvaia C, et al. 1995. Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis. Ophthalmologica 209: 340-345.
-
(1995)
Ophthalmologica
, vol.209
, pp. 340-345
-
-
Incorvaia, C.1
-
40
-
-
47049112234
-
An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling
-
Jing L, et al. 2008. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J. Virol. 82:7120-7134.
-
(2008)
J. Virol.
, vol.82
, pp. 7120-7134
-
-
Jing, L.1
-
41
-
-
0029548268
-
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays
-
Kakkanas A, et al. 1995. Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays. Intervirology 38:346-351.
-
(1995)
Intervirology
, vol.38
, pp. 346-351
-
-
Kakkanas, A.1
-
42
-
-
0027991985
-
Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions
-
Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. 1994. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J. Infect. Dis. 169:956-961.
-
(1994)
J. Infect. Dis.
, vol.169
, pp. 956-961
-
-
Koelle, D.M.1
Abbo, H.2
Peck, A.3
Ziegweid, K.4
Corey, L.5
-
43
-
-
0035869533
-
CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells
-
Koelle DM, et al. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166:4049-4058.
-
(2001)
J. Immunol.
, vol.166
, pp. 4049-4058
-
-
Koelle, D.M.1
-
44
-
-
0037237569
-
Recent progress in herpes simplex virus immunobiology and vaccine research
-
Koelle DM, Corey L. 2003. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Microbiol. Rev. 16:96-113.
-
(2003)
Clin. Microbiol. Rev.
, vol.16
, pp. 96-113
-
-
Koelle, D.M.1
Corey, L.2
-
45
-
-
0028301850
-
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
-
Koelle DM, et al. 1994. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68:2803-2810.
-
(1994)
J. Virol.
, vol.68
, pp. 2803-2810
-
-
Koelle, D.M.1
-
46
-
-
0242300084
-
Immunodominance among herpes simplex virusspecific CD8 T cells expressing a tissue-specific homing receptor
-
Koelle DM, et al. 2003. Immunodominance among herpes simplex virusspecific CD8 T cells expressing a tissue-specific homing receptor. Proc. Natl. Acad. Sci. U.S.A. 100:12899-12904.
-
(2003)
Proc. Natl. Acad. Sci. U.S.A.
, vol.100
, pp. 12899-12904
-
-
Koelle, D.M.1
-
47
-
-
0032703698
-
Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells
-
Kohl S, Sigouroudinia M, Engleman EG. 1999. Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells. Pediatr. Res. 46:755-759.
-
(1999)
Pediatr. Res.
, vol.46
, pp. 755-759
-
-
Kohl, S.1
Sigouroudinia, M.2
Engleman, E.G.3
-
48
-
-
0027223717
-
Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection
-
Kunder SC, Wu L, Morahan PS. 1993. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection. Antiviral Res. 21:103-118.
-
(1993)
Antiviral Res
, vol.21
, pp. 103-118
-
-
Kunder, S.C.1
Wu, L.2
Morahan, P.S.3
-
49
-
-
77957071675
-
Dynamic antibody responses to the Mycobacterium tuberculosis proteome
-
Kunnath-Velayudhan S, et al. 2010. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc. Natl. Acad. Sci. U.S.A. 107:14703-14708.
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 14703-14708
-
-
Kunnath-Velayudhan, S.1
-
50
-
-
0029000226
-
A recombinant glycoprotein vaccine for herpes simplex virus type 2 safety and immunogenicity [corrected]
-
Langenberg AG, et al. 1995. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]. Ann. Intern. Med. 122:889-898.
-
(1995)
Ann. Intern. Med.
, vol.122
, pp. 889-898
-
-
Langenberg, A.G.1
-
51
-
-
0021191322
-
DNA sequence analysis of the typecommon glycoprotein-D genes of herpes simplex virus types 1 and 2
-
Lasky LA, Dowbenko DJ. 1984. DNA sequence analysis of the typecommon glycoprotein-D genes of herpes simplex virus types 1 and 2. DNA 3:23-29.
-
(1984)
DNA
, vol.3
, pp. 23-29
-
-
Lasky, L.A.1
Dowbenko, D.J.2
-
52
-
-
79958002548
-
Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey
-
Liang L, et al. 2011. Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey. Mol. Cell. Proteomics 10:M110.00691.
-
(2011)
Mol. Cell. Proteomics
, vol.10
-
-
Liang, L.1
-
53
-
-
0035827588
-
Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework Analysis of global gene expression in Escherichia coli K12
-
Long AD, et al. 2001. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J. Biol. Chem. 276:19937-19944.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 19937-19944
-
-
Long, A.D.1
-
54
-
-
77955514666
-
High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays
-
Luevano M, et al. 2010. High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology 405:31-40.
-
(2010)
Virology
, vol.405
, pp. 31-40
-
-
Luevano, M.1
-
55
-
-
0025021453
-
Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector
-
Manservigi R, et al. 1990. Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J. Virol. 64:431-436.
-
(1990)
J. Virol.
, vol.64
, pp. 431-436
-
-
Manservigi, R.1
-
56
-
-
0021247875
-
Characterization of the 92 000-dalton glycoprotein induced by herpes simplex virus type 2
-
Marsden HS, Buckmaster A, Palfreyman JW, Hope RG, Minson AC. 1984. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J. Virol. 50:547-554.
-
(1984)
J. Virol.
, vol.50
, pp. 547-554
-
-
Marsden, H.S.1
Buckmaster, A.2
Palfreyman, J.W.3
Hope, R.G.4
Minson, A.C.5
-
57
-
-
0029909383
-
Immunization with DNA vaccines encoding glycoproteinDor glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease
-
McClements WL, Armstrong ME, Keys RD, Liu MA. 1996. Immunization with DNA vaccines encoding glycoproteinDor glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. U.S.A. 93:11414-11420.
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 11414-11420
-
-
McClements, W.L.1
Armstrong, M.E.2
Keys, R.D.3
Liu, M.A.4
-
58
-
-
0025285805
-
Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2
-
McDermott MR, Brais LJ, Evelegh MJ. 1990. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71(Pt 7):1497-1504.
-
(1990)
J. Gen. Virol.
, vol.71
, Issue.PART 7
, pp. 1497-1504
-
-
McDermott, M.R.1
Brais, L.J.2
Evelegh, M.J.3
-
59
-
-
0024560311
-
Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B
-
McDermott MR, Graham FL, Hanke T, Johnson DC. 1989. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169: 244-247.
-
(1989)
Virology
, vol.169
, pp. 244-247
-
-
McDermott, M.R.1
Graham, F.L.2
Hanke, T.3
Johnson, D.C.4
-
60
-
-
0023899276
-
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1
-
McGeoch DJ, et al. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69(Pt 7):1531-1574.
-
(1988)
J. Gen. Virol.
, vol.69
, Issue.PART 7
, pp. 1531-1574
-
-
McGeoch, D.J.1
-
61
-
-
0023205074
-
DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons
-
McGeoch DJ, Moss HW, McNab D, Frame MC. 1987. DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J. Gen. Virol. 68(Pt 1):19-38.
-
(1987)
J. Gen. Virol.
, vol.68
, Issue.PART 1
, pp. 19-38
-
-
McGeoch, D.J.1
Moss, H.W.2
McNab, D.3
Frame, M.C.4
-
62
-
-
0021922525
-
IgG- mediated viral clearance in experimental infection with herpes simplex virus type 1 role for neutralization and Fcdependent functions but notC= cytolysis and C5 chemotaxis
-
McKendall RR. 1985. IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fcdependent functions but notC= cytolysis and C5 chemotaxis. J. Infect. Dis. 151:464-470.
-
(1985)
J. Infect. Dis.
, vol.151
, pp. 464-470
-
-
McKendall, R.R.1
-
63
-
-
0023931237
-
The immunoglobulin response to individual HSV-1 viral polypeptides: kinetics of the response during primary and secondary experimental infection with herpes simplex virus
-
McKendall RR, Pettit M, Woo W. 1988. The immunoglobulin response to individual HSV-1 viral polypeptides: kinetics of the response during primary and secondary experimental infection with herpes simplex virus. J. Med. Microbiol. 25:59-66.
-
(1988)
J. Med. Microbiol.
, vol.25
, pp. 59-66
-
-
McKendall, R.R.1
Pettit, M.2
Woo, W.3
-
64
-
-
0026567934
-
Risk factors for the sexual transmission of genital herpes
-
Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. 1992. Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116:197-202.
-
(1992)
Ann. Intern. Med.
, vol.116
, pp. 197-202
-
-
Mertz, G.J.1
Benedetti, J.2
Ashley, R.3
Selke, S.A.4
Corey, L.5
-
65
-
-
0023883599
-
Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study
-
Mertz GJ, et al. 1988. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J. Infect. Dis. 157:1169-1177.
-
(1988)
J. Infect. Dis.
, vol.157
, pp. 1169-1177
-
-
Mertz, G.J.1
-
66
-
-
0031985087
-
Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes
-
Mikloska Z, Cunningham AL. 1998. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79(Pt 2):353-361.
-
(1998)
J. Gen. Virol.
, vol.79
, Issue.PART 2
, pp. 353-361
-
-
Mikloska, Z.1
Cunningham, A.L.2
-
67
-
-
0030063162
-
Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma
-
Mikloska Z, Kesson AM, Penfold ME, Cunningham AL. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J. Infect. Dis. 173:7-17.
-
(1996)
J. Infect. Dis.
, vol.173
, pp. 7-17
-
-
Mikloska, Z.1
Kesson, A.M.2
Penfold, M.E.3
Cunningham, A.L.4
-
68
-
-
0035155851
-
Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells
-
Morrison LA, Zhu L, Thebeau LG. 2001. Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J. Virol. 75:1195-1204.
-
(2001)
J. Virol.
, vol.75
, pp. 1195-1204
-
-
Morrison, L.A.1
Zhu, L.2
Thebeau, L.G.3
-
69
-
-
34249813713
-
Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses
-
Moutaftsi M, et al. 2007. Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses. J. Immunol. 178:6814-6820.
-
(2007)
J. Immunol.
, vol.178
, pp. 6814-6820
-
-
Moutaftsi, M.1
-
70
-
-
77950865479
-
Uncovering the interplay between CD8 CD4 and antibody responses to complex pathogens
-
Moutaftsi M, et al. 2010. Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol. 5:221-239.
-
(2010)
Future Microbiol
, vol.5
, pp. 221-239
-
-
Moutaftsi, M.1
-
71
-
-
0037446668
-
T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
-
Posavad CM, et al. 2003. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity? J. Immunol. 170:4380-4388.
-
(2003)
J. Immunol.
, vol.170
, pp. 4380-4388
-
-
Posavad, C.M.1
-
72
-
-
0023737057
-
Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice
-
Raizman MB, Foster CS. 1988. Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice. Curr. Eye Res. 7:823-829.
-
(1988)
Curr. Eye Res.
, vol.7
, pp. 823-829
-
-
Raizman, M.B.1
Foster, C.S.2
-
73
-
-
0023937721
-
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination
-
Rooney JF, Wohlenberg C, Cremer KJ, Moss B, Notkins AL. 1988. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J. Virol. 62:1530-1534.
-
(1988)
J. Virol.
, vol.62
, pp. 1530-1534
-
-
Rooney, J.F.1
Wohlenberg, C.2
Cremer, K.J.3
Moss, B.4
Notkins, A.L.5
-
74
-
-
77952669199
-
The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies
-
Scheper T, et al. 2010. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. J. Virol. Methods 166:42-47.
-
(2010)
J. Virol. Methods
, vol.166
, pp. 42-47
-
-
Scheper, T.1
-
75
-
-
9344251685
-
National seroprevalence and trends in herpes simplex virus type 1 in the United States 1976-1994
-
Schillinger JA, et al. 2004. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm. Dis. 31:753-760.
-
(2004)
Sex Transm. Dis.
, vol.31
, pp. 753-760
-
-
Schillinger, J.A.1
-
76
-
-
4344573865
-
Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines
-
Stanberry LR. 2004 Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Herpes 11(Suppl 3):161A-169A.
-
(2004)
Herpes
, vol.11
, Issue.SUPPL. 3
-
-
Stanberry, L.R.1
-
77
-
-
0037153024
-
Glycoprotein-D-adjuvant vaccine to prevent genital herpes
-
Stanberry LR, et al. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347:1652-1661.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 1652-1661
-
-
Stanberry, L.R.1
-
78
-
-
33747886203
-
Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques
-
Sundaresh S, et al. 2006. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22:1760-1766.
-
(2006)
Bioinformatics
, vol.22
, pp. 1760-1766
-
-
Sundaresh, S.1
-
79
-
-
34547852232
-
From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis
-
Sundaresh S, et al. 2007. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 23:i508-i518.
-
(2007)
Bioinformatics
, vol.23
-
-
Sundaresh, S.1
-
80
-
-
1842589394
-
Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1
-
Vollstedt S, et al. 2004. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 78:3846-3850.
-
(2004)
J. Virol.
, vol.78
, pp. 3846-3850
-
-
Vollstedt, S.1
-
81
-
-
0030948337
-
Frequent genital herpes simplex virus 2 shedding in immunocompetent women Effect of acyclovir treatment
-
Wald A, et al. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 99:1092-1097.
-
(1997)
J. Clin. Invest.
, vol.99
, pp. 1092-1097
-
-
Wald, A.1
-
82
-
-
33747627183
-
Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States
-
Xu F, et al. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964-973.
-
(2006)
JAMA
, vol.296
, pp. 964-973
-
-
Xu, F.1
-
83
-
-
34447265951
-
Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a typespecific enzyme-linked immunosorbent assay kit FEMS Immunol
-
Zandi K, et al. 2007. Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a typespecific enzyme-linked immunosorbent assay kit. FEMS Immunol. Med. Microbiol. 50:319-323.
-
(2007)
Med. Microbiol.
, vol.50
, pp. 319-323
-
-
Zandi, K.1
|